3
: 01-11-2014 : 0001 : BROTO : 100 th / LK : GOA : DR. SEMBARANG : 01-11-2014 : 0001 : BROTO : 100 th / LK : GOA : DR. SEMBARANG : 01-11-2014 : 0001 : BROTO : 100 th / LK : GOA : DR. SEMBARANG : 01-11-2014 : 0001 : BROTO : 100 th / LK : GOA : DR. SEMBARANG : 01-11-2014 : 0001 : BROTO : 100 th / LK : GOA : DR. SEMBARANG : 01-11-2014 : 0001 : BROTO : 100 th / LK : GOA : DR. SEMBARANG : 01-11-2014 : 0001 : BROTO : 100 th / LK : GOA : DR. SEMBARANG : 01-11-2014 : 0001 : BROTO : 100 th / LK : GOA : DR. SEMBARANG : 01-11-2014 : 0001 : BROTO : 100 th / LK : GOA : DR. SEMBARANG : 01-11-2014 : 0001 : BROTO : 100 th / LK : GOA : DR. SEMBARANG : 01-11-2014 : 0001 : BROTO : 100 th / LK : GOA : DR. SEMBARANG : 01-11-2014 : 0001 : BROTO : 100 th / LK : GOA : DR. SEMBARANG

trial LABEL RADIOLOGI.doc

Embed Size (px)

Citation preview

Page 1: trial LABEL RADIOLOGI.doc

: 01-11-2014: 0001: BROTO: 100 th / LK: GOA : DR. SEMBARANG

: 01-11-2014: 0001: BROTO: 100 th / LK: GOA : DR. SEMBARANG

: 01-11-2014: 0001: BROTO: 100 th / LK: GOA : DR. SEMBARANG

: 01-11-2014: 0001: BROTO: 100 th / LK: GOA : DR. SEMBARANG

: 01-11-2014: 0001: BROTO: 100 th / LK: GOA : DR. SEMBARANG

: 01-11-2014: 0001: BROTO: 100 th / LK: GOA : DR. SEMBARANG

: 01-11-2014: 0001: BROTO: 100 th / LK: GOA : DR. SEMBARANG

: 01-11-2014: 0001: BROTO: 100 th / LK: GOA : DR. SEMBARANG

: 01-11-2014: 0001: BROTO: 100 th / LK: GOA : DR. SEMBARANG

: 01-11-2014: 0001: BROTO: 100 th / LK: GOA : DR. SEMBARANG

: 01-11-2014: 0001: BROTO: 100 th / LK: GOA : DR. SEMBARANG

: 01-11-2014: 0001: BROTO: 100 th / LK: GOA : DR. SEMBARANG

Page 2: trial LABEL RADIOLOGI.doc

: 01-11-2014: 0001: BROTO: 100 th / LK: GOA : DR. SEMBARANG

: 01-11-2014: 0001: BROTO: 100 th / LK: GOA : DR. SEMBARANG

: 01-11-2014: 0001: BROTO: 100 th / LK: GOA : DR. SEMBARANG

: 01-11-2014: 0001: BROTO: 100 th / LK: GOA : DR. SEMBARANG

Page 3: trial LABEL RADIOLOGI.doc

: 01-11-2014: 0001: BROTO: 100 th / LK: GOA : DR. SEMBARANG

: 01-11-2014: 0001: BROTO: 100 th / LK: GOA : DR. SEMBARANG

: 01-11-2014: 0001: BROTO: 100 th / LK: GOA : DR. SEMBARANG

: 01-11-2014: 0001: BROTO: 100 th / LK: GOA : DR. SEMBARANG


A Randomized Open Label Phase II Trial of Aprepitant ...Protocol No.: 11.0 CONFIDENTIAL Protocol Date: 10/20/14. Clinical Protocol . A Randomized Open Label Phase II Trial of Aprepitant

A Randomized Open Label Phase II Trial of Aprepitant ...Protocol No.: 11.0 CONFIDENTIAL Protocol Date: 10/20/14. Clinical Protocol . A Randomized Open Label Phase II Trial of Aprepitant

Documents
A single-center phase 2 open-label trial evaluating the

A single-center phase 2 open-label trial evaluating the

Documents
A single-center, open-label, exploratory trial of …...Single-center, open-label, exploratory trial. NCT03575806 3 Eligibility Inclusion criteria 1. Be willing and able to provide

A single-center, open-label, exploratory trial of …...Single-center, open-label, exploratory trial. NCT03575806 3 Eligibility Inclusion criteria 1. Be willing and able to provide

Documents
An open-label, single-center, 6-month trial of Theracurmin

An open-label, single-center, 6-month trial of Theracurmin

Documents
Pharmaceutical Benefits Scheme (PBS) | Home€¦ · Web viewThe minor submission presented the results of one pivotal trial, HannaH, a phase III, randomised, open-label trial (see

Pharmaceutical Benefits Scheme (PBS) | Home€¦ · Web viewThe minor submission presented the results of one pivotal trial, HannaH, a phase III, randomised, open-label trial (see

Documents
ION-4 - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/149/ion4_ls.pdfION-4 Trial: Features ION-4 Trial Design: Open-label, single group, phase 3 trial,

ION-4 - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/149/ion4_ls.pdfION-4 Trial: Features ION-4 Trial Design: Open-label, single group, phase 3 trial,

Documents
Randomised trial and open-label extension study of an anti

Randomised trial and open-label extension study of an anti

Documents
Official Title: A RANDOMIZED, MULTICENTER, OPEN-LABEL ...a randomized, multicenter, open-label, phase iii clinical trial to evaluate the efficacy, safety, and pharmacokinetics of prophylactic

Official Title: A RANDOMIZED, MULTICENTER, OPEN-LABEL ...a randomized, multicenter, open-label, phase iii clinical trial to evaluate the efficacy, safety, and pharmacokinetics of prophylactic

Documents
RSK RADIOLOGI.doc

RSK RADIOLOGI.doc

Documents
Design and rationale of a multi-center, pragmatic, open-label ......Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy – the

Design and rationale of a multi-center, pragmatic, open-label ......Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy – the

Documents
Treatment Naïve and Treatment Experienced · COSMOS Trial: Study Features COSMOS Trial: Features Design: Randomized, phase 2a, open-label, using sofosbuvir + simeprevir +/- ribavirin

Treatment Naïve and Treatment Experienced · COSMOS Trial: Study Features COSMOS Trial: Features Design: Randomized, phase 2a, open-label, using sofosbuvir + simeprevir +/- ribavirin

Documents
BASIC HANDLING OF CLINICAL TRIAL SUPPLYbasic handling of clinical trial supply. ... imp labelling –volume 4 annex 13 requirements 5 ... format • if open-label: · 2016-11-9

BASIC HANDLING OF CLINICAL TRIAL SUPPLYbasic handling of clinical trial supply. ... imp labelling –volume 4 annex 13 requirements 5 ... format • if open-label: · 2016-11-9

Documents
MODALITAS RADIOLOGI.doc

MODALITAS RADIOLOGI.doc

Documents
Paper Radiologi.doc

Paper Radiologi.doc

Documents
CLINICAL STUDY PROTOCOL A phase II, open label, non ... SERIO Trial V 2.2.pdf · S.E.R.I.O. TRIAL / vers. No 2.2 – page 1 of 70 CLINICAL STUDY PROTOCOL Title: A phase II, open label,

CLINICAL STUDY PROTOCOL A phase II, open label, non ... SERIO Trial V 2.2.pdf · S.E.R.I.O. TRIAL / vers. No 2.2 – page 1 of 70 CLINICAL STUDY PROTOCOL Title: A phase II, open label,

Documents
Official Title: Phase 2, Open -label, Multiple -dose Trial

Official Title: Phase 2, Open -label, Multiple -dose Trial

Documents
The HiLo Trial - Duke University..., multicenter, cluster-randomized, open-label, non-inferiority, outcomes trial • Compare effects of two different phosphate management strategies

The HiLo Trial - Duke University..., multicenter, cluster-randomized, open-label, non-inferiority, outcomes trial • Compare effects of two different phosphate management strategies

Documents
ALUR DAN SOP RADIOLOGI.doc

ALUR DAN SOP RADIOLOGI.doc

Documents
TITLE PAGE Trial Statistical Analysis Plan...TITLE PAGE Trial Statistical Analysis Plan c02393794-03 BI Trial No.: 1160.106 Title: Open-label,randomized, parallel-group, active-controlled,

TITLE PAGE Trial Statistical Analysis Plan...TITLE PAGE Trial Statistical Analysis Plan c02393794-03 BI Trial No.: 1160.106 Title: Open-label,randomized, parallel-group, active-controlled,

Documents
Sisonke (Together): OPEN LABEL TRIAL CLINICAL TRIAL

Sisonke (Together): OPEN LABEL TRIAL CLINICAL TRIAL

Documents
Food Label Trial Tutorial One Dr Elizabeth Dunford

Food Label Trial Tutorial One Dr Elizabeth Dunford

Documents
Open access Protocol NET-02 trial protocol: a multicentre ... · Batman E, et al. NET-02 trial protocol: a multicentre, randomised, parallel group, open-label, phase II, single- stage

Open access Protocol NET-02 trial protocol: a multicentre ... · Batman E, et al. NET-02 trial protocol: a multicentre, randomised, parallel group, open-label, phase II, single- stage

Documents
Surgical Downstaging in an Open-Label Phase II Trial of ... · Procedures Patients received open-label subcutaneous denosumab 120 mg every 4 weeks, with additional doses administered

Surgical Downstaging in an Open-Label Phase II Trial of ... · Procedures Patients received open-label subcutaneous denosumab 120 mg every 4 weeks, with additional doses administered

Documents
REFRAT MITRAL STENOSIS RADIOLOGI.doc

REFRAT MITRAL STENOSIS RADIOLOGI.doc

Documents
Charles Darwin University A multi-centre open-label ......STUDY PROTOCOL Open Access A multi-centre open-label randomised non-inferiority trial comparing watchful waiting to antibiotic

Charles Darwin University A multi-centre open-label ......STUDY PROTOCOL Open Access A multi-centre open-label randomised non-inferiority trial comparing watchful waiting to antibiotic

Documents
Clinical Trial Protocol · Protocol number EMR200763-004 11/74 1 Summary Protocol number BD1412-63CEC EMR200743-004 Title A randomized, open-label, single dose, 2x2 crossover trial

Clinical Trial Protocol · Protocol number EMR200763-004 11/74 1 Summary Protocol number BD1412-63CEC EMR200743-004 Title A randomized, open-label, single dose, 2x2 crossover trial

Documents
A multi center randomized open label trial on the safety

A multi center randomized open label trial on the safety

Documents
A Randomized Open-label Parallel- group Trial to …...4. Protocol synopsis Title A randomized open-label parallel-group trial is to analyze the efficacy and the efficiency of the

A Randomized Open-label Parallel- group Trial to …...4. Protocol synopsis Title A randomized open-label parallel-group trial is to analyze the efficacy and the efficiency of the

Documents
Safe Medication Administration on the Sterile Field: Sterile Label Trial at Calvary Wakefield Hospital

Safe Medication Administration on the Sterile Field: Sterile Label Trial at Calvary Wakefield Hospital

Health & Medicine
DECISION-CTO - Clinical Trial Resultsclinicaltrialresults.org/Slides/ACC2017/DECISIONCTO_Park.pdf · DECISION CTO Trial Design • DESIGN: a prospective, open-label, randomized trial

DECISION-CTO - Clinical Trial Resultsclinicaltrialresults.org/Slides/ACC2017/DECISIONCTO_Park.pdf · DECISION CTO Trial Design • DESIGN: a prospective, open-label, randomized trial

Documents